Results 281 to 290 of about 100,614 (290)

No gains in efficacy observed by adding gemcitabine to adjuvant therapy for lymph node-positive breast cancer

Ca-A Cancer Journal for Clinicians, 2014
exaly  

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2016
Shaodong Hong, Xuan Wu, Rensheng Wang
exaly  

Gemcitabine

2006
openaire   +1 more source

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

Journal of Clinical Oncology, 2007
Rodryg Adam Ramlau, Johan Filip Vansteenkiste   +1 more
exaly  

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Lancet Oncology, The, 2017
Jeremy S Whelan, Penella J Woll, Gareth J Veal   +2 more
exaly  

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

New England Journal of Medicine, 2018
Thierry Conroy, Alice C Wei, Thierry Lecomte   +2 more
exaly  

Gemcitabine

Reactions Weekly, 2012
openaire   +2 more sources

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Journal of Clinical Oncology, 2005
exaly  

Gemcitabine

Reactions Weekly, 2000
openaire   +1 more source

Gemcitabine

Reactions Weekly, 2003
openaire   +1 more source